Literature DB >> 22977467

Ostrich produce cross-reactive neutralization antibodies against pandemic influenza virus A/H1N1 following immunization with a seasonal influenza vaccine.

Kazuhide Adachi1, Kentaro Takama, Masaya Tsukamoto, Marie Inai, Ekowati Handharyani, Satoshi Hiroi, Yasuhiro Tsukamoto.   

Abstract

An outbreak of influenza in 2009 was found to be caused by a novel strain of influenza virus designated as pandemic influenza A/H1N1 2009. Vaccination with recent seasonal influenza vaccines induced little or no cross-reactive antibody response to the pandemic influenza virus A/H1N1 2009 in any age group in human populations. Accordingly, most people had low immunity against this pathogen, thus resulting in the worldwide spread of the infection to produce a so-called 'pandemic'. This report presents the important finding that ostrich eggs generate cross-reactive antibodies to the pandemic influenza virus A/H1N1 following immunization of female ostrich with a seasonal influenza vaccine. This simple method produced a large amount of antibodies against influenza viruses by one female ostrich. An enzyme-linked immunosorbent assay (ELISA) and immunocytochemistry indicated that the ostrich antibodies possessed strong cross-reactivity to the pandemic A/H1N1 as well as to the seasonal A/H1N1, A/H3N2 and B viruses. The hemaggregation activities of erythrocytes induced by this pandemic strain were also inhibited by the ostrich antibodies. In addition, the cytopathological effects of infection with a pandemic virus on MDCK cells were clearly inhibited in co-cultures with the ostrich antibodies, thereby indicating the neutralization of viral infectivity in the cells. In conclusion, cross-reactive neutralization antibodies against pandemic influenza virus A/H1N1 2009 were successfully generated in ostrich eggs produced by females immunized with seasonal influenza viral vaccine.

Entities:  

Year:  2010        PMID: 22977467      PMCID: PMC3440658          DOI: 10.3892/etm.2010.180

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  14 in total

1.  [Polyclonal avian antibodies extracted from egg yolk as an alternative to the production of antibodies in mammals - a review]

Authors:  Rüdiger Schade; Anne Schniering; Andreas Hlinak
Journal:  ALTEX       Date:  1992       Impact factor: 6.043

2.  Potential role of SC1, a cell adhesion molecule, in mammary gland tumors.

Authors:  Kazuhide Adachi; Kenji Hagimori; Hidenori Kato; Keiko Fukuda; Masaharu Kikuta; Yasuhiro Tsukamoto
Journal:  Mol Med Rep       Date:  2008 Mar-Apr       Impact factor: 2.952

3.  Development of neutralization antibodies against highly pathogenic H5N1 avian influenza virus using ostrich (Struthio camelus) yolk.

Authors:  Kazuhide Adachi; Ekowati Handharyani; Dwi Kesuma Sari; Kentaro Takama; Keiko Fukuda; Isako Endo; Ryohei Yamamoto; Masaki Sawa; Masaru Tanaka; Itsuro Konishi; Yasuhiro Tsukamoto
Journal:  Mol Med Rep       Date:  2008 Mar-Apr       Impact factor: 2.952

Review 4.  Protecting healthcare workers from pandemic influenza: N95 or surgical masks?

Authors:  Jan Gralton; Mary-Louise McLaws
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

Review 5.  Chicken antibodies: taking advantage of evolution--a review.

Authors:  A Larsson; R M Bålöw; T L Lindahl; P O Forsberg
Journal:  Poult Sci       Date:  1993-10       Impact factor: 3.352

6.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Authors:  Kathy Hancock; Vic Veguilla; Xiuhua Lu; Weimin Zhong; Eboneé N Butler; Hong Sun; Feng Liu; Libo Dong; Joshua R DeVos; Paul M Gargiullo; T Lynnette Brammer; Nancy J Cox; Terrence M Tumpey; Jacqueline M Katz
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

7.  Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Authors:  Rebecca J Garten; C Todd Davis; Colin A Russell; Bo Shu; Stephen Lindstrom; Amanda Balish; Wendy M Sessions; Xiyan Xu; Eugene Skepner; Varough Deyde; Margaret Okomo-Adhiambo; Larisa Gubareva; John Barnes; Catherine B Smith; Shannon L Emery; Michael J Hillman; Pierre Rivailler; James Smagala; Miranda de Graaf; David F Burke; Ron A M Fouchier; Claudia Pappas; Celia M Alpuche-Aranda; Hugo López-Gatell; Hiram Olivera; Irma López; Christopher A Myers; Dennis Faix; Patrick J Blair; Cindy Yu; Kimberly M Keene; P David Dotson; David Boxrud; Anthony R Sambol; Syed H Abid; Kirsten St George; Tammy Bannerman; Amanda L Moore; David J Stringer; Patricia Blevins; Gail J Demmler-Harrison; Michele Ginsberg; Paula Kriner; Steve Waterman; Sandra Smole; Hugo F Guevara; Edward A Belongia; Patricia A Clark; Sara T Beatrice; Ruben Donis; Jacqueline Katz; Lyn Finelli; Carolyn B Bridges; Michael Shaw; Daniel B Jernigan; Timothy M Uyeki; Derek J Smith; Alexander I Klimov; Nancy J Cox
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

8.  N-95 face mask for prevention of bird flu virus: an appraisal of nanostructure and implication for infectious control.

Authors:  Viroj Wiwanitkit
Journal:  Lung       Date:  2006-11-03       Impact factor: 2.584

9.  Phylogen of immunoglobulin structure and function. 3. Immunoglobulins of the chicken.

Authors:  G A Leslie; L W Clem
Journal:  J Exp Med       Date:  1969-12-01       Impact factor: 14.307

10.  Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918.

Authors:  Martha I Nelson; Cécile Viboud; Lone Simonsen; Ryan T Bennett; Sara B Griesemer; Kirsten St George; Jill Taylor; David J Spiro; Naomi A Sengamalay; Elodie Ghedin; Jeffery K Taubenberger; Edward C Holmes
Journal:  PLoS Pathog       Date:  2008-02-29       Impact factor: 6.823

View more
  2 in total

Review 1.  Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.

Authors:  Isabelle Legastelois; Sophie Buffin; Isabelle Peubez; Charlotte Mignon; Régis Sodoyer; Bettina Werle
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

Review 2.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.